Standard Operating Procedure for Volunteer Identification and Screening Logs in BA/BE Studies
Department | BA-BE Studies |
---|---|
SOP No. | SOP/BA-BE/105/2025 |
Supersedes | SOP/BA-BE/105/2022 |
Page No. | Page 1 of 9 |
Issue Date | 17/04/2025 |
Effective Date | 20/04/2025 |
Review Date | 17/04/2026 |
1. Purpose
To define the procedure for proper identification, unique ID assignment, and documentation of volunteer screening and eligibility logs in Bioavailability/Bioequivalence (BA/BE) studies, ensuring compliance with regulatory and ethical standards.
2. Scope
This SOP is applicable to all clinical trial personnel involved in volunteer recruitment, screening, enrollment, and maintenance of subject screening documentation at the clinical site.
3. Responsibilities
- Clinical Research Coordinator
4. Accountability
The Principal Investigator is accountable for ensuring that volunteer identification and screening records are maintained accurately and securely, and that only eligible volunteers are enrolled based on validated documentation.
5. Procedure
5.1 Volunteer Identification and ID Assignment
- Upon first contact, assign a temporary screening number (e.g., SCR-105-001).
- If eligible post-screening, assign a permanent Volunteer ID (e.g., VOL-105-001) for use in CRFs, sample labels, etc.
- Enter details into Annexure-1: Volunteer Screening and ID Log.
5.2 Screening Process Documentation
- Record each volunteer’s:
- Name
- Contact details
- Date of screening
- Screening status (Pass/Fail)
- Capture reasons for screening failure, if any (e.g., out-of-range vitals, lab abnormality).
- Use Annexure-2: Volunteer Screening Outcome Form for each individual.
5.3 Updating Logs and Traceability
- Ensure logs are updated on the same day of the screening.
- All records must be signed and dated by the CRC or PI.
- Cross-verify paper records with digital logs weekly (Annexure-3: Log Verification Checklist).
5.4 Record Confidentiality
- Store screening logs with personal identifiers in a locked file room with restricted access.
- Volunteer IDs used in study records must not reveal names or contact information.
5.5 Archival
- At the end of study, archive all screening logs with study documentation.
- Maintain logs for the period defined by the sponsor/regulatory agency (typically 5 years).
6. Abbreviations
- BA: Bioavailability
- BE: Bioequivalence
- CRC: Clinical Research Coordinator
- PI: Principal Investigator
- ID: Identification
7. Documents
- Volunteer Screening and ID Log – Annexure-1
- Volunteer Screening Outcome Form – Annexure-2
- Log Verification Checklist – Annexure-3
8. References
- ICH E6(R2) – Good Clinical Practice
- Indian GCP Guidelines
- Schedule Y – Drugs and Cosmetics Rules
9. SOP Version
Version: 2.0
10. Approval Section
Prepared By | Checked By | Approved By | |
---|---|---|---|
Signature | |||
Date | |||
Name | |||
Designation | |||
Department |
11. Annexures
Annexure-1: Volunteer Screening and ID Log
SCR No. | VOL ID | Full Name | Screening Date | Status | Remarks |
---|---|---|---|---|---|
SCR-105-001 | VOL-105-001 | Rajesh Kumar | 12/04/2025 | Passed | Eligible |
Annexure-2: Volunteer Screening Outcome Form
Volunteer Name | Date of Screening | Tests Performed | Result | Screening Status | Comments |
---|---|---|---|---|---|
Sunita Reddy | 14/04/2025 | Vitals, Labs | Normal | Passed | Ready for dosing |
Annexure-3: Log Verification Checklist
Date | Verified By | Discrepancies Found | Corrective Action |
---|---|---|---|
15/04/2025 | QA Officer | None | NA |
Revision History:
Revision Date | Revision No. | Details | Reason | Approved By |
---|---|---|---|---|
10/01/2022 | 1.0 | Initial Release | GCP Requirement | QA Head |
17/04/2025 | 2.0 | Annexures added; electronic verification added | Process Improvement | QA Head |